Race and Medicine. David Rotman.
by Rotman, David; ProQuest Information and Learning Company.
Series: SIRS Enduring Issues 2006Article 9Health. Publisher: Technology Review, 2005ISSN: 1522-323X;.Subject(s): African Americans -- Diseases | Angiotensin converting enzyme -- Inhibitors | BiDil | Heart failure | Medicine -- Research | Race -- Genetic aspects | Race differences | United States Food and Drug AdmDDC classification: 050 Summary: "The roughly five million Americans who suffer from heart failure, a chronic and deadly disease, could be part of a radical change in the practice of medicine later this year [2005]. Cardiologists across the country will likely begin to prescribe a new, and by most accounts highly promising, drug based on an unusual criterion: whether the patient is black or white--or, to be more precise, whether the person identifies him- or herself as an African American." (TECHNOLOGY REVIEW) This article discusses whether or not the FDA will approve a new drug that is "targeted exclusively at a specific racial group" and examines the controversy over "race-based medicines."| Item type | Current location | Call number | Status | Date due |
|---|---|---|---|---|
Books
|
High School - old - to delete | REF SIRS 2006 Health Article 9 (Browse shelf) | Available |
Articles Contained in SIRS Enduring Issues 2006.
Originally Published: Race and Medicine, April 2005; pp. 60-65.
"The roughly five million Americans who suffer from heart failure, a chronic and deadly disease, could be part of a radical change in the practice of medicine later this year [2005]. Cardiologists across the country will likely begin to prescribe a new, and by most accounts highly promising, drug based on an unusual criterion: whether the patient is black or white--or, to be more precise, whether the person identifies him- or herself as an African American." (TECHNOLOGY REVIEW) This article discusses whether or not the FDA will approve a new drug that is "targeted exclusively at a specific racial group" and examines the controversy over "race-based medicines."
Records created from non-MARC resource.
There are no comments for this item.